Nebenwirkungen · Sitagliptin Accord
Sitagliptin Accord 25 mg film-coated tablets Sitagliptin Accord 50 mg film-coated tablets Sitagliptin Accord 100 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8
HOS-148071 · Präparat HOS-099826
Some adverse reactions were observed more frequently in studies of combination use of sitagliptin with other anti-diabetic medicinal products than in studies of sitagliptin monotherapy. These included hypoglycaemia (frequency very common with the combination of sulphonylurea and metformin), influenza (common with insulin [with or without metformin]), nausea and vomiting (common with metformin), flatulence (common with metformin or pioglitazone), constipation (common with the combination of sulphonylurea and metformin), peripheral oedema (common with pioglitazone or the combination of pioglitazone and metformin), somnolence and diarrhoea (uncommon with metformin), and dry mouth (uncommon with insulin [with or without metformin]).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-01-27T15:33:00Z · SHA-256 bea58f9fde8e11591ed9625cec516482359c02eeb5f49a1055538124cd0defc2 · Passage 2ce83277b89f978ab8536092c7c9472477533e254a8e37af73845e5f562a7b53 · Zeichen 4419–5157 im Abschnitt